← Return to Why are dosages for estrogen suppression drugs one-size-fits-all?

Discussion
gldilli avatar

Why are dosages for estrogen suppression drugs one-size-fits-all?

Breast Cancer | Last Active: Apr 19 1:45pm | Replies (103)
Comment receiving replies
Profile picture for queenofjacks @queenofjacks

https://hospitalpharmacyeurope.com/clinical-zones/oncology/aromatase-inhibitors-reduce-breast-cancer-recurrence-risk-more-than-tamoxifen/

Jump to this post

Replies to "https://hospitalpharmacyeurope.com/clinical-zones/oncology/aromatase-inhibitors-reduce-breast-cancer-recurrence-risk-more-than-tamoxifen/"
orsejr | @orsejr | Oct 6, 2023

Use Predict Breast tool. This tool can tell you the benefit of taking hormone therapy .

VIEW AND REPLY
whitehairwisdom | @whitehairwisdom | Mar 12 8:26am

@queenofjacks perhaps I'm not comprehending what that article is saying but to me, it has conflicting info re: percentages reducing risk of recurrence.

"Moreover, AI's have also been found to reduce recurrence rates of breast cancer by about 30% compared to Tamoxifen in postmenopausal women".

"The authors concluded that compared to Tamoxifen, use of an AI, reduced the risk of breast cancer recurrence by 3% at 5 & 10 years".

VIEW AND REPLY